ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于2023年度计提资产减值准备的公告 | 2024-04-25 | Chinese | |
| 独立董事2023年度述职报告（汪献忠） | 2024-04-25 | Chinese | |
| 关于变更经营范围并修改《公司章程》的公告 | 2024-04-25 | Chinese | |
| 关于召开2023年年度股东大会的通知 | 2024-04-25 | Chinese | |
| 关于提请股东大会授权董事会办理以简易程序向特定对象发行股票相关事宜的公告 | 2024-04-25 | Chinese | |
| 2024年一季度报告（更新前） | 2024-04-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 36040550 | 关于2023年度计提资产减值准备的公告 | 2024-04-25 | Chinese | ||
| 36040540 | 独立董事2023年度述职报告（汪献忠） | 2024-04-25 | Chinese | ||
| 36040531 | 关于变更经营范围并修改《公司章程》的公告 | 2024-04-25 | Chinese | ||
| 36040521 | 关于召开2023年年度股东大会的通知 | 2024-04-25 | Chinese | ||
| 36040507 | 关于提请股东大会授权董事会办理以简易程序向特定对象发行股票相关事宜的公告 | 2024-04-25 | Chinese | ||
| 36040498 | 2024年一季度报告（更新前） | 2024-04-25 | Chinese | ||
| 36040488 | 关于使用闲置自有资金进行现金管理的公告 | 2024-04-25 | Chinese | ||
| 36040480 | 2023年度财务决算报告 | 2024-04-25 | Chinese | ||
| 36040468 | 公司章程（2024年4月） | 2024-04-25 | Chinese | ||
| 36040458 | 关于股东减持计划期限届满的公告 | 2024-04-24 | Chinese | ||
| 36040450 | 关于公司实际控制人部分股份质押的公告 | 2024-02-26 | Chinese | ||
| 36040442 | 关于公司法定代表人变更完成工商登记的公告 | 2024-02-02 | Chinese | ||
| 36040436 | 2023年年度业绩预告 | 2024-01-26 | Chinese | ||
| 36040431 | 2024年第一次临时股东大会决议公告 | 2024-01-10 | Chinese | ||
| 36040424 | 2024年第一次临时股东大会法律意见书 | 2024-01-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.